Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 3,030.00
+385.00 (14.56%)
At close: Jul 31, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 10.84 billion as of July 31, 2026. Its market cap has decreased by -4.27% in one year.
Market Cap
10.84B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
9.21
Stock Price
3,030.00
ChartMarket Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 10.84B, a decrease of -54.01%. That is a compound annual growth rate of -24.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 10.84B | -14.89% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLscience | 26.89B |
| Pharmsville | 26.66B |
| Seoul Pharma | 23.21B |
| Daesung Microbiological Labs. | 23.18B |
| Hurum | 20.95B |
| BIFIDO | 20.04B |
| Union Korea Pharm | 19.70B |
| ChoA Pharmaceutical Co., LTD. | 18.12B |